
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
frizzled-10 CRISPR/Cas9 KO Plasmid (h) | sc-406690 | 20 µg | $397.00 |
FZD10 encodes frizzled-10, a seven-transmembrane WNT receptor that regulates signal transduction through canonical β-catenin–dependent transcription and non-canonical pathways controlling planar cell polarity and calcium flux. By shaping receptor–ligand interactions at the cell surface, frizzled-10 influences developmental patterning, epithelial–mesenchymal programs, and tissue homeostasis. Dysregulated FZD10 activity and altered WNT/Frizzled signaling are frequently studied in the context of oncogenic signaling networks, tumor cell invasion, and aberrant differentiation states. FZD10 is also used as a pathway node for dissecting crosstalk between WNT cues and growth factor–responsive transcriptional programs.
frizzled-10 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the FZD10 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the FZD10 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the FZD10 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish frizzled-10 protein expression.
This CRISPR knockout system enables efficient generation of FZD10-deficient cell models for investigation of frizzled-10 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.